Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients.
Eur J Endocrinol. 2021 Feb;184(2):311-320.
Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells.
FASEB J. 2021 Feb;35(2):e21314.
Clinical aspects of multiple endocrine neoplasia type 1.
Nat Rev Endocrinol. 2021 Feb 9.